OMER FY2025 SEC EDGAR DEF 14A #145 of 168 in industry

Omeros Corp CEO pay ratio

The CEO earned $1.5M in FY2025 against median worker pay of $191,656 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
WA
Filing date
2026-04-30
Industry
Chemicals & Pharmaceuticals
Industry rank
#145/168

Data updated August 2026

Subscribe to Omeros Corp CEO pay filing updates (RSS)

CEO-to-worker pay ratio
8:1
Below Average (Scale: 0–1000:1)
CEO pay
$1.5M
Median worker
$191,656

Answer first

Omeros Corp's FY2025 CEO total of $1.5M ranks #1184 of 1,423 complete filings; its 8:1 pay ratio ranks #1297. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $191,656. Industry placement uses the FY2025 SIC-28 peer cohort (# 145 of 168, 14th percentile - among the lower quartile of industry peers by pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#1184
$1.5M of 1,423 FY2025
Ratio rank
#1297
8:1 of 1,423
Industry pct
14th
among the lower quartile of industry peers by pay ratio

How Omeros Corp ranks nationally

Omeros Corp CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$1,533,248 17th percentile higher than 17% of 1,423 companies

$0–$2,500,000: 304 companies (21%). This entry sits in this band. $2,500,000–$5,000,000: 182 companies (13%). Above this entry. $5,000,000–$7,500,000: 208 companies (15%). Above this entry. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Omeros Corp vs. Chemicals & Pharmaceuticals peers

CEO total pay ($1.5M) against pay ratio (8:1) for Omeros Corp (marked) and its 4 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both727977.32606242.44484507.56362772.68241037.86.3:115.7:125.0:134.4:143.7:1CEO total payPay ratio (CEO : median worker)Omeros Corp, CEO total pay: 1533248 · Pay ratio (CEO : median worker): 8:1Omeros CorpCollegium Pharmaceutical, Inc, CEO total pay: 1715846 · Pay ratio (CEO : median worker): 8:1Collegium Pharmaceutical, IncDenali Therapeutics Inc., CEO total pay: 2966856 · Pay ratio (CEO : median worker): 8:1Denali Therapeutics Inc.MoonLake Immunotherapeutics, CEO total pay: 1897240 · Pay ratio (CEO : median worker): 8:1MoonLake ImmunotherapeuticsAmerican Vanguard Corp, CEO total pay: 1069480 · Pay ratio (CEO : median worker): 8:1American Vanguard Corp
Omeros Corp vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Omeros Corp's structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Omeros Corp

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
8:1
FY2025
vs prior FY
+3:1
from FY2024 5:1
CEO $ YoY
+67%
$1.5M latest
Filings shown
5
FY2021–2025
Omeros Corp CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $1.1M - $182,467 6:1 -
2022 $696K -36% $173,998 4:1 -2:1
2023 $1.5M +116% $188,271 8:1 +4:1
2024 $918K -39% $183,614 5:1 -3:1
2025 $1.5M +67% $191,656 8:1 +3:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1285819, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
8:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$1.5M
Companies in Industry
168
vs. Industry Median
Below
#145 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Omeros Corp: near-parity Item 402(u) ratio

Omeros Corp's FY2025 ratio 8:1 ranks #145 of 168 Chemicals & Pharmaceuticals filers (14th percentile). the CEO earned 8× the median employee ($191,656) in FY2025.

At $191,656 median worker pay, the FLOOR stamp is near pay-parity territory under LIGHT CEO total.

CEO Total Pay

$1.5M

FY2025 Summary Compensation, below median

Pay Ratio

8:1

Below typical

Omeros Corp in the lower Chemicals & Pharmaceuticals third

Omeros Corp's FY2025 ratio 8:1 ranks #145 of 168 Chemicals & Pharmaceuticals filers (14th percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Omeros Corp's $1.5M CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #1184 and ratio rank #1297 split - treat 8:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$1.5M
Median Employee Pay
$191,656
Pay Ratio
8:1
Filing Date
2026-04-30

Company Info

Ticker
OMER
CIK
1285819
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
WA
View SEC filings →
SEC EDGAR DEF 14A for CIK 1285819, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Omeros Corp's FY2025 ratio 8:1 ranks #145 of 168 Chemicals & Pharmaceuticals filers (14th percentile).

Read with Omeros Corp

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps FLOOR · LIGHT · ELITE-MED.

Arrow Financial Corp · LIGHT

ABS(ceo_total_comp) peer at $1.6M (Δ $28K heavier vs Omeros Corp); MODEST · PAR-MED vs this page's FLOOR · LIGHT · ELITE-MED.
Berkshire Hathaway Inc · LIGHT

ABS(ceo_total_comp) peer at $1.5M (Δ $34K lighter vs Omeros Corp); FLOOR · HIGH-MED vs this page's FLOOR · LIGHT · ELITE-MED.
First Internet Bancorp · LIGHT

ABS(ceo_total_comp) peer at $1.5M (Δ $41K lighter vs Omeros Corp); FLOOR · HIGH-MED vs this page's FLOOR · LIGHT · ELITE-MED.
AGNT, Inc. · LIGHT

ABS(ceo_total_comp) peer at $1.6M (Δ $42K heavier vs Omeros Corp); FLOOR · PAR-MED vs this page's FLOOR · LIGHT · ELITE-MED.
Collegium Pharmaceutical, Inc (SIC 28 pole)

Collegium Pharmaceutical, Inc stamps FLOOR · LIGHT nearest in-SIC by ABS(pay_ratio) to Omeros Corp's FLOOR filing.
National dual ranks · #1184/#1297

Omeros Corp's FY2025 package sits #1184 by CEO dollars and #1297 by ratio under LIGHT · FLOOR.
Ratio primer · FLOOR

Omeros Corp's FLOOR stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Omeros Corp (CIK 1285819), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.